• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data.

作者信息

Yoo Sang Gune K, Chung Grace S, Bahendeka Silver K, Sibai Abla M, Damasceno Albertino, Farzadfar Farshad, Rohloff Peter, Houehanou Corine, Norov Bolormaa, Karki Khem B, Azangou-Khyavy Mohammadreza, Marcus Maja E, Aryal Krishna K, Brant Luisa C C, Theilmann Michaela, Cífková Renata, Lunet Nuno, Gurung Mongal S, Mwangi Joseph Kibachio, Martins Joao, Haghshenas Rosa, Sturua Lela, Vollmer Sebastian, Bärnighausen Till, Atun Rifat, Sussman Jeremy B, Singh Kavita, Moghaddam Sahar Saeedi, Guwatudde David, Geldsetzer Pascal, Manne-Goehler Jennifer, Huffman Mark D, Davies Justine I, Flood David

机构信息

Cardiovascular Division, Department of Internal Medicine, Washington University in St Louis, St Louis, MO, USA.

Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

出版信息

Glob Heart. 2024 May 3;19(1):44. doi: 10.5334/gh.1323. eCollection 2024.

DOI:10.5334/gh.1323
PMID:38708405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11067965/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed6/11067965/d3bdbb24657e/gh-19-1-1323-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed6/11067965/d3bdbb24657e/gh-19-1-1323-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed6/11067965/d3bdbb24657e/gh-19-1-1323-g1.jpg

相似文献

1
Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data.阿司匹林用于心血管疾病一级预防的全球流行情况：一项基于全国代表性个体水平数据的横断面研究。
Glob Heart. 2024 May 3;19(1):44. doi: 10.5334/gh.1323. eCollection 2024.
2
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.阿司匹林用于心血管疾病和癌症一级预防的预防性使用：系统评价和综述概述。
Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430.
3
A systematic review of aspirin in primary prevention: is it time for a new approach?阿司匹林在一级预防中的系统评价：是时候采用新方法了吗？
Am J Cardiovasc Drugs. 2015 Apr;15(2):113-33. doi: 10.1007/s40256-014-0100-5.
4
[Primary cardiovascular prevention with aspirin].[阿司匹林用于心血管疾病的一级预防]
Semergen. 2015 Jul-Aug;41(5):279-81. doi: 10.1016/j.semerg.2014.12.004. Epub 2015 Jan 23.
5
Prevalence of high on-treatment platelet reactivity in diabetic patients treated with aspirin.阿司匹林治疗的糖尿病患者中治疗后血小板高反应性的发生率。
Am J Med. 2014 Jan;127(1):95.e1-9. doi: 10.1016/j.amjmed.2013.09.019. Epub 2013 Oct 8.
6
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.阿司匹林在男性和女性动脉粥样硬化性心血管疾病二级预防中的剂量：ADAPTABLE 随机临床试验的二次分析。
JAMA Cardiol. 2024 Sep 1;9(9):808-816. doi: 10.1001/jamacardio.2024.1712.
7
Aspirin for primary prevention in the elderly.阿司匹林用于老年人的一级预防。
Aging (Albany NY). 2019 Sep 6;11(17):6618-6619. doi: 10.18632/aging.102255.
8
Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.他汀类药物在心血管疾病一级预防中的成本效益：比利时的系统评价与经济分析
Acta Cardiol. 2009 Feb;64(1):1-10. doi: 10.2143/AC.64.1.2034354.
9
Aspirin is indicated for primary prevention of cardiovascular events in HIV-infected patients.阿司匹林适用于HIV感染患者心血管事件的一级预防。
J Acquir Immune Defic Syndr. 2010 Aug;54(5):560. doi: 10.1097/QAI.0b013e3181d913fd.
10
Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.阿司匹林用于糖尿病患者心血管疾病及全因死亡事件的一级预防：随机对照试验的最新荟萃分析
Diabet Med. 2017 Mar;34(3):316-327. doi: 10.1111/dme.13133. Epub 2016 May 22.

引用本文的文献

1
Effect of aspirin use on conversion risk from mild cognitive impairment to Alzheimer's disease.阿司匹林使用对轻度认知障碍转化为阿尔茨海默病风险的影响。
Front Aging Neurosci. 2025 Aug 6;17:1603892. doi: 10.3389/fnagi.2025.1603892. eCollection 2025.
2
Global research trends and hotspots in aspirin studies (2014-2024): a bibliometric perspective.阿司匹林研究的全球研究趋势与热点（2014 - 2024）：文献计量学视角
Front Pharmacol. 2025 May 16;16:1513318. doi: 10.3389/fphar.2025.1513318. eCollection 2025.
3
Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges.

本文引用的文献

1
Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries.阿司匹林用于 51 个低收入、中等收入和高收入国家的心血管疾病二级预防。
JAMA. 2023 Aug 22;330(8):715-724. doi: 10.1001/jama.2023.12905.
2
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.阿司匹林用于预防心血管疾病和结直肠癌：美国预防服务工作组的更新建模研究。
JAMA. 2022 Apr 26;327(16):1598-1607. doi: 10.1001/jama.2022.3385.
3
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.
慢性淋巴细胞白血病中新型疗法与伴随用药的管理：关键挑战
Front Pharmacol. 2025 Jan 3;15:1517972. doi: 10.3389/fphar.2024.1517972. eCollection 2024.
世界卫生组织心血管疾病风险图表：修订后的模型可估算 21 个全球区域的风险。
Lancet Glob Health. 2019 Oct;7(10):e1332-e1345. doi: 10.1016/S2214-109X(19)30318-3. Epub 2019 Sep 2.
4
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
5
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.评估医疗保险患者心血管预防治疗的长期风险和益处：百万心脏纵向动脉粥样硬化性心血管疾病风险评估工具：美国心脏协会和美国心脏病学会特别报告
Circulation. 2017 Mar 28;135(13):e793-e813. doi: 10.1161/CIR.0000000000000467. Epub 2016 Nov 4.
6
The answer is 17 years, what is the question: understanding time lags in translational research.答案是 17 年，问题是：理解转化研究中的时间滞后。
J R Soc Med. 2011 Dec;104(12):510-20. doi: 10.1258/jrsm.2011.110180.